Woman pausing during a busy day with a hand resting lightly over her abdomen in a bright home setting.

Colostrum and the Intestinal Lining

Explore the intestinal lining, the research into bovine colostrum and the importance of collection timing, quality and dose.

The intestinal lining is both a gateway and a boundary. It allows digested nutrients and water to pass into the body while helping keep unwanted material within the digestive tract. This selective function depends on mucus, closely connected intestinal cells, local immune activity and the continual renewal of the lining itself.

Bovine colostrum contains proteins and bioactive components that have been investigated in relation to this barrier. Human research has produced encouraging findings in selected settings, particularly when intestinal permeability is temporarily increased, but the evidence is not uniform. Colostrum should therefore be discussed as nutritional support not as a proven treatment or a product that can “seal” every person’s gut.

  • The intestinal lining selectively absorbs nutrients and water while helping limit the passage of unwanted material.
  • Bovine colostrum has been studied in relation to intestinal permeability and markers of intestinal-cell stress, with promising but mixed results.
  • Study dose cannot be interpreted alone: collection timing, processing and product bioactivity can materially affect what a gram of colostrum represents.

The surface of the gastrointestinal tract is covered by a specialised layer of epithelial cells. These cells are joined by structures often described as tight junctions. Together with the mucus layer, they regulate the movement of water, nutrients and other material between the gut and the rest of the body.

The lining is not a fixed wall. Its cells are continually renewed, and its permeability changes in response to normal digestion, physical activity and other physiological demands. Local immune cells and the microorganisms living in the gut also interact closely with this environment.

“Intestinal permeability” describes how readily substances pass across the lining. Researchers can estimate it with tests involving specific sugars or with markers associated with intestinal-cell stress. These measurements are useful in research, but they are not the same as diagnosing a person from a list of general symptoms.

The intestinal lining responds to many everyday influences. Intense or prolonged exercise particularly in heat can temporarily alter blood flow to the digestive tract and increase some permeability or cell-stress markers. Illness, medication use and diagnosed gastrointestinal conditions can also affect the lining, although these situations require individual medical assessment.

Sleep, hydration, diet and training load can influence digestive comfort, but discomfort alone does not identify its cause. The popular phrase “leaky gut” is often used broadly online, while clinical research usually refers to measured intestinal permeability in a defined population and under specific conditions.

This distinction matters. A study involving athletes after strenuous exercise cannot automatically be applied to every person with bloating, pain or altered bowel habits. Persistent or concerning symptoms should be assessed rather than self-diagnosed as an intestinal-barrier problem.

Bovine colostrum naturally contains immunoglobulins, lactoferrin, peptides and growth-related factors. Researchers have examined how the combined material interacts with intestinal cells and the local gut environment. Laboratory studies have explored cell growth, migration and barrier resistance, while human trials have measured permeability and markers of intestinal-cell stress.

These lines of research provide a plausible reason to investigate bovine colostrum, but a mechanism observed in cells or animals is not proof of a health outcome in people. Likewise, identifying a component in colostrum does not establish that every finished supplement contains the same concentration or biological activity.

For everyday communication, the most accurate conclusion is that bovine colostrum contains naturally occurring components studied for their potential role in supporting normal intestinal-lining function. Stronger treatment or repair claims would go beyond the available evidence.

A 2024 systematic review and meta-analysis examined randomized trials of bovine colostrum in healthy athletes and patients. The pooled results showed reductions in two urinary sugar-ratio measures of intestinal permeability, but not in the blood marker intestinal fatty acid-binding protein. The authors also reported substantial variation between studies and called for further trials that account for product quality, dose and duration.

Small exercise studies help explain both the interest and the uncertainty. In one double-blind crossover study, 12 volunteers used bovine colostrum or placebo for 14 days before a standardized exercise challenge. The rise in a permeability measure was smaller after the colostrum period. In contrast, another randomized crossover study using a weight-based dose of 1.7 g/kg/day for seven days found no observable benefit on permeability-related, physiological or performance outcomes during exercise in heat.

These trials involved specific exercise stressors, small participant groups and research products that were not MIP Colostrum. Their results should not be converted into a guarantee for general digestive symptoms or for MIP users.

Colostrum changes rapidly after calving. A 2020 randomized, double-blind study gave healthy athletes 500mg twice daily 1g/day of colostrum collected at 2, 24 or 72 hours after delivery, or a whey placebo. Only the colostrum collected at 2 and 24 hours produced a significant within-group reduction in the permeability measure, and the clearest comparison favoured the 2-hour product over placebo and the 72-hour product. This study does not establish an ideal consumer dose, but it shows why grams alone can be misleading.

A separate 2020 laboratory and animal study compared 20 commercial bovine-colostrum products and reported approximately six-fold differences in two measures of cell-related bioactivity. It also found a marked decline in bioactivity across later milkings. The authors were affiliated with a colostrum supplier, and the work did not compare clinical outcomes in people, but it reinforces the need to report product characteristics rather than treating all colostrum powders as interchangeable.

MIP Colostrum is produced from fresh, never-frozen New Zealand colostrum collected from the first two milkings and is batch verified at 20–25% IgG. These are transparent quality specifications. They do not prove that MIP will reproduce the outcome of a study conducted with a different product.

Trials in intestinal-permeability and sports settings have used very different protocols. Some used around 10–20g/day, some used weight-based doses, and the study comparing different collection times described above used 1g/day. Duration, participant type, exercise challenge and measured outcome also differed.

MIP’s standard adult serving is 2g daily. With batch-verified IgG of 20–25%, this provides approximately 400–500mg of IgG per serving. This quantifies one important aspect of the MIP product, but IgG percentage is not a complete measure of every bioactive component.

It would therefore be inaccurate to claim that 2g of MIP is clinically equivalent or superior to 10g, 20g or a weight-based dose of another product. It would be equally incomplete to judge the studies only by their number of grams when collection timing, composition, processing and bioactivity were not consistently disclosed.

Colostrum should sit within a broader approach to digestive wellbeing. A varied diet, adequate fluid intake, appropriate physical activity, sufficient sleep and medical care when needed remain more important than relying on one supplement.

For adults who choose MIP Colostrum, the standard serving is 2g daily. Consistent use according to the product directions is more appropriate than increasing the amount in an attempt to reproduce a research protocol involving another product.

MIP Colostrum is a food supplement, not a treatment for inflammatory bowel disease, infection, food allergy or another gastrointestinal condition. Anyone with diagnosed digestive disease, persistent pain, bleeding, unexplained weight loss, ongoing diarrhoea or constipation, milk allergy, pregnancy, medication use or other individual concerns should seek professional advice.

Choose MIP Colostrum in the format that suits you

Complement your daily routine with Omega-3 Krill Oil.

Continue exploring

Related reading

Have a question about MIP Colostrum?

Visit our Frequently Asked Questions or contact the MIP team.

References

  1. Hajihashemi P, et al. Bovine colostrum in increased intestinal permeability in healthy athletes and patients: a meta-analysis of randomized clinical trials. European Journal of Clinical Nutrition. 2024. PMID: 38361147.
  2. Marchbank T, Davison G, Oakes JR, et al. The nutriceutical bovine colostrum truncates the increase in gut permeability caused by heavy exercise in athletes. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2011;300(3):G477–G484. doi:10.1152/ajpgi.00281.2010.
  3. Morrison SA, Cheung SS, Cotter JD. Bovine colostrum, training status, and gastrointestinal permeability during exercise in the heat: a placebo-controlled double-blind study. Applied Physiology, Nutrition, and Metabolism. 2014;39(9):1070–1082. doi:10.1139/apnm-2013-0583.
  4. Hałasa M, Maciejewska-Markiewicz D, Baśkiewicz-Hałasa M, Safranow K, Stachowska E. Post-delivery milking delay influence on the effect of oral supplementation with bovine colostrum as measured with intestinal permeability test. Medicina. 2020;56(10):495. PMID: 32987647.
  5. Playford RJ, Cattell M, Marchbank T. Marked variability in bioactivity between commercially available bovine colostrum for human use; implications for clinical trials. PLoS ONE. 2020;15(6):e0234719. doi:10.1371/journal.pone.0234719. Note: the authors were affiliated with a bovine-colostrum supplier.
  6. Chandwe K, Kelly P. Colostrum therapy for human gastrointestinal health and disease. Nutrients. 2021;13(6):1956. doi:10.3390/nu13061956.

This article provides general nutritional information and is not intended to diagnose, treat, cure or prevent any disease. Individual needs vary. Follow the product label and seek advice from a qualified health professional where appropriate.